The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
申请公布号
SI2635601(T1)
申请公布日期
2017.01.31
申请号
SI20110030958
申请日期
2011.11.02
申请人
Boehringer Ingelheim International GmbH
发明人
BARRETT Rachel Rebecca;CANADA Keith;CATRON Katrina Mary;COPENHAVER Robert;FREGO Lee Edward;RAYMOND Ernest Lee;SINGH Sanjaya;ZHU Xiangyang
